id sg-nus-scholar.10635-178675
record_format dspace
spelling sg-nus-scholar.10635-1786752023-09-06T08:49:23Z A systematic review and network meta-analysis of immunotherapy and targeted therapy for advanced melanoma da Silveira Nogueira Lima, J.P Georgieva, M Haaland, B de Lima Lopes, G DUKE-NUS MEDICAL SCHOOL B Raf kinase carboplatin cobimetinib cytotoxic T lymphocyte antigen 4 dabrafenib dacarbazine ipilimumab mitogen activated protein kinase nivolumab paclitaxel pembrolizumab placebo programmed death 1 ligand 1 selumetinib temozolomide ticilimumab trametinib vemurafenib immunological antineoplastic agent Article cancer immunotherapy dosage schedule comparison drug dose comparison drug efficacy gene mutation human melanoma meta analysis molecularly targeted therapy overall survival priority journal progression free survival qualitative analysis randomized controlled trial (topic) systematic review disease free survival immunotherapy melanoma treatment outcome Antineoplastic Agents, Immunological Disease-Free Survival Humans Immunotherapy Melanoma Molecular Targeted Therapy Randomized Controlled Trials as Topic Treatment Outcome 10.1002/cam4.1001 Cancer Medicine 6 6 1143-1153 2020-10-21T07:52:04Z 2020-10-21T07:52:04Z 2017 Article da Silveira Nogueira Lima, J.P, Georgieva, M, Haaland, B, de Lima Lopes, G (2017). A systematic review and network meta-analysis of immunotherapy and targeted therapy for advanced melanoma. Cancer Medicine 6 (6) : 1143-1153. ScholarBank@NUS Repository. https://doi.org/10.1002/cam4.1001 20457634 https://scholarbank.nus.edu.sg/handle/10635/178675 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic B Raf kinase
carboplatin
cobimetinib
cytotoxic T lymphocyte antigen 4
dabrafenib
dacarbazine
ipilimumab
mitogen activated protein kinase
nivolumab
paclitaxel
pembrolizumab
placebo
programmed death 1 ligand 1
selumetinib
temozolomide
ticilimumab
trametinib
vemurafenib
immunological antineoplastic agent
Article
cancer immunotherapy
dosage schedule comparison
drug dose comparison
drug efficacy
gene mutation
human
melanoma
meta analysis
molecularly targeted therapy
overall survival
priority journal
progression free survival
qualitative analysis
randomized controlled trial (topic)
systematic review
disease free survival
immunotherapy
melanoma
treatment outcome
Antineoplastic Agents, Immunological
Disease-Free Survival
Humans
Immunotherapy
Melanoma
Molecular Targeted Therapy
Randomized Controlled Trials as Topic
Treatment Outcome
spellingShingle B Raf kinase
carboplatin
cobimetinib
cytotoxic T lymphocyte antigen 4
dabrafenib
dacarbazine
ipilimumab
mitogen activated protein kinase
nivolumab
paclitaxel
pembrolizumab
placebo
programmed death 1 ligand 1
selumetinib
temozolomide
ticilimumab
trametinib
vemurafenib
immunological antineoplastic agent
Article
cancer immunotherapy
dosage schedule comparison
drug dose comparison
drug efficacy
gene mutation
human
melanoma
meta analysis
molecularly targeted therapy
overall survival
priority journal
progression free survival
qualitative analysis
randomized controlled trial (topic)
systematic review
disease free survival
immunotherapy
melanoma
treatment outcome
Antineoplastic Agents, Immunological
Disease-Free Survival
Humans
Immunotherapy
Melanoma
Molecular Targeted Therapy
Randomized Controlled Trials as Topic
Treatment Outcome
da Silveira Nogueira Lima, J.P
Georgieva, M
Haaland, B
de Lima Lopes, G
A systematic review and network meta-analysis of immunotherapy and targeted therapy for advanced melanoma
description 10.1002/cam4.1001
author2 DUKE-NUS MEDICAL SCHOOL
author_facet DUKE-NUS MEDICAL SCHOOL
da Silveira Nogueira Lima, J.P
Georgieva, M
Haaland, B
de Lima Lopes, G
format Article
author da Silveira Nogueira Lima, J.P
Georgieva, M
Haaland, B
de Lima Lopes, G
author_sort da Silveira Nogueira Lima, J.P
title A systematic review and network meta-analysis of immunotherapy and targeted therapy for advanced melanoma
title_short A systematic review and network meta-analysis of immunotherapy and targeted therapy for advanced melanoma
title_full A systematic review and network meta-analysis of immunotherapy and targeted therapy for advanced melanoma
title_fullStr A systematic review and network meta-analysis of immunotherapy and targeted therapy for advanced melanoma
title_full_unstemmed A systematic review and network meta-analysis of immunotherapy and targeted therapy for advanced melanoma
title_sort systematic review and network meta-analysis of immunotherapy and targeted therapy for advanced melanoma
publishDate 2020
url https://scholarbank.nus.edu.sg/handle/10635/178675
_version_ 1779152349520986112